SASIWAN KAMTHONG: Open Payments
NPI 1457308967 · GARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,354 in 47 payments from 13 companies in 2025. Trend: 2023 $447 · 2024 $828 · 2025 $1,354
Food & beverage: $1,354
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 18 | $406 |
| Amgen Inc. | 6 | $218 |
| Novo Nordisk Inc | 3 | $157 |
| AstraZeneca Pharmaceuticals LP | 7 | $152 |
| Boston Scientific Corporation | 1 | $146 |
| Lilly USA, LLC | 3 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| Cipher Pharmaceuticals US LLC | 1 | $51 |
| SANOFI-AVENTIS U.S. LLC | 1 | $28 |
| Corcept Therapeutics | 1 | $20 |
Products named: Kerendia, AMS 700, REPATHA, Ozempic, JARDIANCE, OTEZLA, BREZTRI, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
